About Haptogen Haptogen, founded in 2002, focuses on drug discovery and development of therapeutic antibodies that bind haptens (eg hormones and cell signalling molecules) and haptenic structures (defined protein epitopes, glycosylation and phosphorylation states). This approach enables Haptogen to reach previously non-accessible targets. Haptogen's in-house clinical focus is in infectious, renal and metabolic diseases. The company applies its SmartTargets strategy, based on the propriety Haptomics( platform technology, to select low-risk targets for its own product pipeline but also against partner targets. In addition to therapeutic applications the technology has been applied to clinical, biochip and environmental diagnostics. Haptogen is building value by developing orphan indication compounds for in- house development and partnering these compounds to addresst unmet medical needs. The company is led by a highly experienced commercially minded management team backed up with internationally recognised academic and scientific expertise.
| Website | http://www.haptogen.com |
| Revenue | $5.4 million |
| Employees | View employees |
| Address | Polwarth Building Foresterhill, Aberdeen, Aberdeen City AB25 2ZD, GB |
| Phone | +44 1224 555889 |
| Industry | Manufacturing General, Biotechnology, Manufacturing, Science and Engineering, Life Insurance, Financial Services, Pharmaceutical, Health Care |
| Competitors | Purple, Sleep Number Corporation, Leesa Sleep, Sleep Innovations, Tempur-Pedic Official, Hug Sleep, Dreampad, Sleepace, smartsleep®, Tomorrow Sleep +21 more (view full list) |
| SIC | SIC Code 28 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 32 Companies, NAICS Code 325 Companies, NAICS Code 3254 Companies |
Looking for a particular Haptogen employee's phone or email?
Haptogen Questions
The Haptogen annual revenue was $5.4 million in 2026.
Haptogen is based in Aberdeen, Aberdeen City.
The NAICS codes for Haptogen are [32, 325, 3254].
The SIC codes for Haptogen are [28, 283].
